These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 37344)
81. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity. Levey GS; Levey BA; Ruiz E; Lehotay DC Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927 [No Abstract] [Full Text] [Related]
82. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity. Lehotay DC; Levey BA; Rogerson BJ; Levey GS Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040 [TBL] [Abstract][Full Text] [Related]
83. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity. Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566 [No Abstract] [Full Text] [Related]
84. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs. Lehotay DC; Levey BA; Levey GS Biomed Pharmacother; 1983; 37(7):312-6. PubMed ID: 6141818 [TBL] [Abstract][Full Text] [Related]
85. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Gewirtz DA Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079 [TBL] [Abstract][Full Text] [Related]
86. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity. Levey GS; Levey BA; Ruiz E; Lehotay DC J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344 [No Abstract] [Full Text] [Related]